ASIA: +91 96043 17127 | USA: 1 (347) 690-0211 | Translate : 

Covid-19

Anticoagulants Market

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

report img

Anticoagulants Market By Drug Class (NOACs, Heparin & LMWH, Vitamin K Antagonist, and Others), and By Application (Stroke, Atrial Fibrillation, Pulmonary Embolism (PE), Deep Vein Thrombosis (DVT), and Others) : Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026

Industry Insights

[185+ Pages PDF Report] Global Anticoagulants market was approximately USD 27 Billion in 2019 and is anticipated to reach over USD 44 billion by 2026, at a CAGR of 7.8% during the forecast period.

This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the Anticoagulants industry. The report analyzes and declares the historical and current trends analysis of the Anticoagulants industry and subsequently recommends the projected trends anticipated to be observed in the Anticoagulants market during the upcoming years.

The Anticoagulants market report analyzes and notifies the industry statistics at the global as well as regional and country levels in order to acquire a thorough perspective of the entire Anticoagulants market. The historical and past insights are provided for FY 2016 to FY 2019 whereas projected trends are delivered for FY 2020 to FY 2026. The quantitative and numerical data is represented in terms of value (USD Million) from FY 2016 – 2026.

The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the Anticoagulants industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.

Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the Anticoagulants industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the Anticoagulants market.

The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders involved in the entire value chain of the Anticoagulants industry. The Anticoagulants market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.

The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the Anticoagulants sector. Key strategic developments in the Anticoagulants market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the Anticoagulants market are appropriately highlighted in the report.

The Anticoagulants market research report delivers an acute valuation and taxonomy of the Anticoagulants industry by practically splitting the market on the basis of different types, categories, and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026. The regional segmentation of the Anticoagulants industry includes the complete classification of all the major continents including North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. Further, country-wise data for the Anticoagulants industry is provided for the leading economies of the world.

Increased occurrences of chronic and cardiovascular disease, increased acceptance of novel oral anticoagulants (NOACs) and increased knowledge of the use of NOACs, increased population aging, lack of specific anticoagulant alternatives, advantageous government policies and an increasing number of obese individuals are key drivers of this problem. Increased investment by leading market players in developing new products and providing solutions to meet high patient needs would provide new opportunities for market players in the anticoagulant industry to develop new products. However, the high cost of NOACs, the existence of alternative medicines, strict government control, the risk of side effects, and complications in oral anticoagulants may limit global demand for anticoagulants.

The anticoagulant market is segmented based on drug type and region. On the basis of drug type segmentation, the market is classified into antidepressant drugs, mood stabilizers, antipsychotics drugs, and others.

logoTop Market Players

Some of the essential players operating in the Anticoagulants market, but not restricted to include Glaxo SmithKline (GSK), Eli Lilly, AstraZeneca, Pfizer Inc., Janssen Pharmaceuticals, AbbVie Inc., Novartis AG, Bristol-Myers Squibb Company Allergan Plc., Otsuka Holdings Co. Ltd., and Others.

logoThe taxonomy of the Anticoagulants Market by its scope and segmentation is as follows:

logoGlobal Anticoagulants Market: By Drug Class Segmentation Analysis

  • NOACs
  • Heparin & LMWH
  • Vitamin K Antagonist
  • Others

logoGlobal Anticoagulants Market: By Application Segmentation Analysis

  • Stroke
  • Atrial Fibrillation
  • Pulmonary Embolism (PE)
  • Deep Vein Thrombosis (DVT)
  • Others

logoGlobal Anticoagulants Market: Regional Segmentation Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • The UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table of Content

  1. CHAPTER 1. Executive Summary
  2. CHAPTER 2. Anticoagulants market – Drug Class Analysis
    1. 2.1. Global Anticoagulants Market – Drug Class Overview
    2. 2.2. Global Anticoagulants Market Share, by Drug Class, 2019 & 2026 (USD Billion)
    3. 2.3. NOACs
      1. 2.3.1. Global NOACs Anticoagulants Market, 2016-2026 (USD Billion)
    4. 2.4. Heparin & LMWH
      1. 2.4.1. Global Heparin & LMWH Anticoagulants Market, 2016-2026 (USD Billion)
    5. 2.5. Vitamin K Antagonist
      1. 2.5.1. Global Vitamin K Antagonist Anticoagulants Market, 2016-2026 (USD Billion)
    6. 2.6. Others
      1. 2.6.1. Global Others Anticoagulants Market, 2016-2026 (USD Billion)
  3. CHAPTER 3. Anticoagulants market – Application Analysis
    1. 3.1. Global Anticoagulants Market – Application Overview
    2. 3.2. Global Anticoagulants Market Share, by Application, 2019 & 2026 (USD Billion)
    3. 3.3. Stroke
      1. 3.3.1. Global Stroke Anticoagulants Market, 2016-2026 (USD Billion)
    4. 3.4. Atrial Fibrillation
      1. 3.4.1. Global Atrial Fibrillation Anticoagulants Market, 2016-2026 (USD Billion)
    5. 3.5. Pulmonary Embolism (PE)
      1. 3.5.1. Global Pulmonary Embolism (PE) Anticoagulants Market, 2016-2026 (USD Billion)
    6. 3.6. Deep Vein Thrombosis (DVT)
      1. 3.6.1. Global Deep Vein Thrombosis (DVT) Anticoagulants Market, 2016-2026 (USD Billion)
    7. 3.7. Others
      1. 3.7.1. Global Others Anticoagulants Market, 2016-2026 (USD Billion)
  4. CHAPTER 4. Anticoagulants market – Regional Analysis
    1. 4.1. Global Anticoagulants Market Regional Overview
    2. 4.2. Global Anticoagulants Market Share, by Region, 2019 & 2026 (Value)
    3. 4.3. North America
      1. 4.3.1. North America Anticoagulants Market size and forecast, 2016-2026
      2. 4.3.2. North America Anticoagulants Market, by Country, 2019 & 2026 (USD Billion)
      3. 4.3.3. North America Anticoagulants Market, by Drug Class, 2016-2026
        1. 4.3.3.1. North America Anticoagulants Market, by Drug Class, 2016-2026 (USD Billion)
      4. 4.3.4. North America Anticoagulants Market, by Application, 2016-2026
        1. 4.3.4.1. North America Anticoagulants Market, by Application, 2016-2026 (USD Billion)
      5. 4.3.5. U.S.
        1. 4.3.5.1. U.S. Market size and forecast, 2016-2026 (USD Billion)
      6. 4.3.6. Canada
        1. 4.3.6.1. Canada Market size and forecast, 2016-2026 (USD Billion)
    4. 4.4. Europe
      1. 4.4.1. Europe Anticoagulants Market size and forecast, 2016-2026
      2. 4.4.2. Europe Anticoagulants Market, by Country, 2019 & 2026 (USD Billion)
      3. 4.4.3. Europe Anticoagulants Market, by Drug Class, 2016-2026
        1. 4.4.3.1. Europe Anticoagulants Market, by Drug Class, 2016-2026 (USD Billion)
      4. 4.4.4. Europe Anticoagulants Market, by Application, 2016-2026
        1. 4.4.4.1. Europe Anticoagulants Market, by Application, 2016-2026 (USD Billion)
      5. 4.4.5. Germany
        1. 4.4.5.1. Germany Market size and forecast, 2016-2026 (USD Billion)
      6. 4.4.6. France
        1. 4.4.6.1. France Market size and forecast, 2016-2026 (USD Billion)
      7. 4.4.7. U.K.
        1. 4.4.7.1. U.K. Market size and forecast, 2016-2026 (USD Billion)
      8. 4.4.8. Italy
        1. 4.4.8.1. Italy Market size and forecast, 2016-2026 (USD Billion)
      9. 4.4.9. Spain
        1. 4.4.9.1. Spain Market size and forecast, 2016-2026 (USD Billion)
      10. 4.4.10. Rest of Europe
        1. 4.4.10.1. Rest of Europe Market size and forecast, 2016-2026 (USD Billion)
    5. 4.5. Asia Pacific
      1. 4.5.1. Asia Pacific Anticoagulants Market size and forecast, 2016-2026
      2. 4.5.2. Asia Pacific Anticoagulants Market, by Country, 2019 & 2026 (USD Billion)
      3. 4.5.3. Asia Pacific Anticoagulants Market, by Drug Class, 2016-2026
        1. 4.5.3.1. Asia Pacific Anticoagulants Market, by Drug Class, 2016-2026 (USD Billion)
      4. 4.5.4. Asia Pacific Anticoagulants Market, by Application, 2016-2026
        1. 4.5.4.1. Asia Pacific Anticoagulants Market, by Application, 2016-2026 (USD Billion)
      5. 4.5.5. China
        1. 4.5.5.1. China Market size and forecast, 2016-2026 (USD Billion)
      6. 4.5.6. Japan
        1. 4.5.6.1. Japan Market size and forecast, 2016-2026 (USD Billion)
      7. 4.5.7. India
        1. 4.5.7.1. India Market size and forecast, 2016-2026 (USD Billion)
      8. 4.5.8. South Korea
        1. 4.5.8.1. South Korea Market size and forecast, 2016-2026 (USD Billion)
      9. 4.5.9. South-East Asia
        1. 4.5.9.1. South-East Asia Market size and forecast, 2016-2026 (USD Billion)
      10. 4.5.10. Rest of Asia Pacific
        1. 4.5.10.1. Rest of Asia Pacific Market size and forecast, 2016-2026 (USD Billion)
    6. 4.6. Latin America
      1. 4.6.1. Latin America Anticoagulants Market size and forecast, 2016-2026
      2. 4.6.2. Latin America Anticoagulants Market, by Country, 2019 & 2026 (USD Billion)
      3. 4.6.3. Latin America Anticoagulants Market, by Drug Class, 2016-2026
        1. 4.6.3.1. Latin America Anticoagulants Market, by Drug Class, 2016-2026 (USD Billion)
      4. 4.6.4. Latin America Anticoagulants Market, by Application, 2016-2026
        1. 4.6.4.1. Latin America Anticoagulants Market, by Application, 2016-2026 (USD Billion)
      5. 4.6.5. Brazil
        1. 4.6.5.1. Brazil Market size and forecast, 2016-2026 (USD Billion)
      6. 4.6.6. Mexico
        1. 4.6.6.1. Mexico Market size and forecast, 2016-2026 (USD Billion)
      7. 4.6.7. Rest of Latin America
        1. 4.6.7.1. Rest of Latin America Market size and forecast, 2016-2026 (USD Billion)
    7. 4.7. The Middle-East and Africa
      1. 4.7.1. The Middle-East and Africa Anticoagulants Market size and forecast, 2016-2026
      2. 4.7.2. The Middle-East and Africa Anticoagulants Market, by Country, 2019 & 2026 (USD Billion)
      3. 4.7.3. The Middle-East and Africa Anticoagulants Market, by Drug Class, 2016-2026
        1. 4.7.3.1. The Middle-East and Africa Anticoagulants Market, by Drug Class, 2016-2026 (USD Billion)
      4. 4.7.4. The Middle-East and Africa Anticoagulants Market, by Application, 2016-2026
        1. 4.7.4.1. The Middle-East and Africa Anticoagulants Market, by Application, 2016-2026 (USD Billion)
      5. 4.7.5. GCC Countries
        1. 4.7.5.1. GCC Countries Market size and forecast, 2016-2026 (USD Billion)
      6. 4.7.6. South Africa
        1. 4.7.6.1. South Africa Market size and forecast, 2016-2026 (USD Billion)
      7. 4.7.7. Rest of Middle-East Africa
        1. 4.7.7.1. Rest of Middle-East Africa Market size and forecast, 2016-2026 (USD Billion)
  5. CHAPTER 5. Anticoagulants market – Competitive Landscape
    1. 5.1. Competitor Market Share – Revenue
    2. 5.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
    3. 5.3. Strategic Development
      1. 5.3.1. Acquisitions and Mergers
      2. 5.3.2. New Products
      3. 5.3.3. Research & Development Activities
  6. CHAPTER 6. Company Profiles
    1. 6.1. Aspen Holdings
      1. 6.1.1. Company Overview
      2. 6.1.2. Aspen Holdings Revenue and Gross Margin
      3. 6.1.3. Product portfolio
      4. 6.1.4. Recent initiatives
    2. 6.2. Bayer AG
      1. 6.2.1. Company Overview
      2. 6.2.2. Bayer AG Revenue and Gross Margin
      3. 6.2.3. Product portfolio
      4. 6.2.4. Recent initiatives
    3. 6.3. Boehringer Ingelheim GmbH
      1. 6.3.1. Company Overview
      2. 6.3.2. Boehringer Ingelheim GmbH Revenue and Gross Margin
      3. 6.3.3. Product portfolio
      4. 6.3.4. Recent initiatives
    4. 6.4. Portola Pharmaceuticals Inc.
      1. 6.4.1. Company Overview
      2. 6.4.2. Portola Pharmaceuticals Inc. Revenue and Gross Margin
      3. 6.4.3. Product portfolio
      4. 6.4.4. Recent initiatives
    5. 6.5. Bristol-Myers Squibb Company
      1. 6.5.1. Company Overview
      2. 6.5.2. Bristol-Myers Squibb Company Revenue and Gross Margin
      3. 6.5.3. Product portfolio
      4. 6.5.4. Recent initiatives
    6. 6.6. Daiichi Sankyo Company Limited
      1. 6.6.1. Company Overview
      2. 6.6.2. Daiichi Sankyo Company Limited Revenue and Gross Margin
      3. 6.6.3. Product portfolio
      4. 6.6.4. Recent initiatives
    7. 6.7. GlaxoSmithKline
      1. 6.7.1. Company Overview
      2. 6.7.2. GlaxoSmithKline Revenue and Gross Margin
      3. 6.7.3. Product portfolio
      4. 6.7.4. Recent initiatives
    8. 6.8. Sanofi S.A.
      1. 6.8.1. Company Overview
      2. 6.8.2. Sanofi S.A. Revenue and Gross Margin
      3. 6.8.3. Product portfolio
      4. 6.8.4. Recent initiatives
    9. 6.9. Pfizer Inc.
      1. 6.9.1. Company Overview
      2. 6.9.2. Pfizer Inc. Revenue and Gross Margin
      3. 6.9.3. Product portfolio
      4. 6.9.4. Recent initiatives
    10. 6.10. Johnson & Johnson
      1. 6.10.1. Company Overview
      2. 6.10.2. Johnson & Johnson Revenue and Gross Margin
      3. 6.10.3. Product portfolio
      4. 6.10.4. Recent initiatives
  7. CHAPTER 7. Anticoagulants — Industry Analysis
    1. 7.1. Anticoagulants Market – Key Trends
      1. 7.1.1. Market Drivers
      2. 7.1.2. Market Restraints
      3. 7.1.3. Market Opportunities
    2. 7.2. Value Chain Analysis
    3. 7.3. Technology Roadmap and Timeline
    4. 7.4. Anticoagulants Market – Attractiveness Analysis
      1. 7.4.1. By Drug Class
      2. 7.4.2. By Application
      3. 7.4.3. By Region
  8. CHAPTER 8. Marketing Strategy Analysis, Distributors
    1. 8.1. Marketing Channel
    2. 8.2. Direct Marketing
    3. 8.3. Indirect Marketing
    4. 8.4. Marketing Channel Development Trend
    5. 8.5. Economic/Political Environmental Change
  9. CHAPTER 9. Report Conclusion
  10. CHAPTER 10. Research Approach & Methodology
    1. 10.1. Report Description
    2. 10.2. Research Scope
    3. 10.3. Research Methodology
      1. 10.3.1. Secondary Research
      2. 10.3.2. Primary Research
      3. 10.3.3. Models
        1. 10.3.3.1. Company Share Analysis Model
        2. 10.3.3.2. Revenue Based Modeling
        3. 10.3.3.3. Research Limitations

        List of Figures

        FIG. 1 Global Anticoagulants Market, 2016-2026 (USD Billion)
        FIG. 2 Global Anticoagulants Market Share, by Drug Class, 2019 & 2026 (USD Billion)
        FIG. 3 Global NOACs Anticoagulants Market, 2016-2026 (USD Billion)
        FIG. 4 Global Heparin & LMWH Anticoagulants Market, 2016-2026 (USD Billion)
        FIG. 5 Global Vitamin K Antagonist Anticoagulants Market, 2016-2026 (USD Billion)
        FIG. 6 Global Others Anticoagulants Market, 2016-2026 (USD Billion)
        FIG. 7 Global Anticoagulants Market Share, by Application, 2019 & 2026 (USD Billion)
        FIG. 8 Global Stroke Anticoagulants Market, 2016-2026 (USD Billion)
        FIG. 9 Global Atrial Fibrillation Anticoagulants Market, 2016-2026 (USD Billion)
        FIG. 10 Global Pulmonary Embolism (PE) Anticoagulants Market, 2016-2026 (USD Billion)
        FIG. 11 Global Deep Vein Thrombosis (DVT) Anticoagulants Market, 2016-2026 (USD Billion)
        FIG. 12 Global Others Anticoagulants Market, 2016-2026 (USD Billion)
        FIG. 13 Global Anticoagulants Market Share, by Region, 2019 & 2026
        FIG. 14 North America Anticoagulants Market, 2016-2026
        FIG. 15 U.S. Anticoagulants Market, 2016-2026
        FIG. 16 Canada Anticoagulants Market, 2016-2026
        FIG. 17 Europe Anticoagulants Market, 2016-2026
        FIG. 18 Germany Anticoagulants Market, 2016-2026
        FIG. 19 France Anticoagulants Market, 2016-2026
        FIG. 20 U.K. Anticoagulants Market, 2016-2026
        FIG. 21 Italy Anticoagulants Market, 2016-2026
        FIG. 22 Spain Anticoagulants Market, 2016-2026
        FIG. 23 Rest of Europe Anticoagulants Market, 2016-2026
        FIG. 24 Asia Pacific Anticoagulants Market, 2016-2026
        FIG. 25 China Anticoagulants Market, 2016-2026
        FIG. 26 Japan Anticoagulants Market, 2016-2026
        FIG. 27 India Anticoagulants Market, 2016-2026
        FIG. 28 South  Korea Anticoagulants Market, 2016-2026
        FIG. 29 South-East Asia Anticoagulants Market, 2016-2026
        FIG. 30 Rest of Asia Pacific Anticoagulants Market, 2016-2026
        FIG. 31 Latin America Anticoagulants Market, 2016-2026
        FIG. 32 Brazil Anticoagulants Market, 2016-2026
        FIG. 33 Mexico Anticoagulants Market, 2016-2026
        FIG. 34 Rest of Latin America Anticoagulants Market, 2016-2026
        FIG. 35 The Middle-East and Africa Anticoagulants Market, 2016-2026
        FIG. 36 GCC Countries Anticoagulants Market, 2016-2026
        FIG. 37 South Africa Anticoagulants Market, 2016-2026
        FIG. 38 Rest of Middle-East Africa Anticoagulants Market, 2016-2026
        FIG. 39 Competitor Market Share – Revenue
        FIG. 40 Aspen Holdings Revenue and Growth Rate
        FIG. 41 Aspen Holdings Market Share
        FIG. 42 Bayer AG Revenue and Growth Rate
        FIG. 43 Bayer AG Market Share
        FIG. 44 Boehringer Ingelheim GmbH Revenue and Growth Rate
        FIG. 45 Boehringer Ingelheim GmbH Market Share
        FIG. 46 Portola Pharmaceuticals Inc. Revenue and Growth Rate
        FIG. 47 Portola Pharmaceuticals Inc. Market Share
        FIG. 48 Bristol-Myers Squibb Company Revenue and Growth Rate
        FIG. 49 Bristol-Myers Squibb Company Market Share
        FIG. 50 Daiichi Sankyo Company Limited Revenue and Growth Rate
        FIG. 51 Daiichi Sankyo Company Limited Market Share
        FIG. 52 GlaxoSmithKline Revenue and Growth Rate
        FIG. 53 GlaxoSmithKline Market Share
        FIG. 54 Sanofi S.A. Revenue and Growth Rate
        FIG. 55 Sanofi S.A. Market Share
        FIG. 56 Pfizer Inc. Revenue and Growth Rate
        FIG. 57 Pfizer Inc. Market Share
        FIG. 58 Johnson & Johnson Revenue and Growth Rate
        FIG. 59 Johnson & Johnson Market Share
        FIG. 60 Market Dynamics
        FIG. 61 Global Anticoagulants – Value Chain Analysis
        FIG. 62 Technology Roadmap and Timeline
        FIG. 63 Market Attractiveness Analysis – By Drug Class
        FIG. 64 Market Attractiveness Analysis – By Application
        FIG. 65 Market Attractiveness Analysis – By Region
        FIG. 66 Market Channel
        FIG. 67 Marketing Channel Development Trend
        FIG. 68 Growth in World Gross Product, 2008-2019

        List of Tables

        TABLE 1 Global Anticoagulants Market, 2019 & 2026 (USD Billion)
        TABLE 2 Global Anticoagulants market, by Drug Class, 2016-2026 (USD Billion)
        TABLE 3 Global Anticoagulants market, by Application, 2016-2026 (USD Billion)
        TABLE 4 Global Anticoagulants market, by Region, 2016-2026 (USD Billion)
        TABLE 5 North America Anticoagulants Market, by Drug Class, 2016-2026 (USD Billion)
        TABLE 6 North America Anticoagulants Market, by Application, 2016-2026 (USD Billion)
        TABLE 7 Europe Anticoagulants Market, by Drug Class, 2016-2026 (USD Billion)
        TABLE 8 Europe Anticoagulants Market, by Application, 2016-2026 (USD Billion)
        TABLE 9 Asia Pacific Anticoagulants Market, by Drug Class, 2016-2026 (USD Billion)
        TABLE 10 Asia Pacific Anticoagulants Market, by Application, 2016-2026 (USD Billion)
        TABLE 11 Latin America Anticoagulants Market, by Drug Class, 2016-2026 (USD Billion)
        TABLE 12 Latin America Anticoagulants Market, by Application, 2016-2026 (USD Billion)
        TABLE 13 The Middle-East and Africa Anticoagulants Market, by Drug Class, 2016-2026 (USD Billion)
        TABLE 14 The Middle-East and Africa Anticoagulants Market, by Application, 2016-2026 (USD Billion)
        TABLE 15 Global Anticoagulants Market - Company Revenue Analysis 2016-2019 (USD Billion)
        TABLE 16 Global Anticoagulants Market - Company Revenue Share Analysis 2016-2019(%)
        TABLE 17 Acquisitions and Mergers
        TABLE 18 New Product/Service Launch
        TABLE 19 Research & Development Activities
        TABLE 20 Market Drivers
        TABLE 21 Market Restraints
        TABLE 22 Market Opportunities

Key Insights from Primary Research

  • According to the primary CXO’s of the global Anticoagulants market, the market is estimated to witness a substantial growth of nearly 7.8% over the forecast period.
  • The market was valued at USD 27 billion, in 2019 and is expected to be valued over USD 44 billion.
  • On the basis of the drug class segment, NOACs dominated the global Anticoagulants market in 2019. In terms of revenue, it accounted for more than a 38% share of the total market in 2019.
  • Asia Pacific market is expected to be the fastest goring region for Anticoagulants over the forecast period owing to growing investments for R&D and pharmaceutical companies in the region.
  • By geography, the North America region headed the market with a share of above 31%, in 2019.

Key Recommendations from Analysts

  • Higher prevalence of chronic disorder, technological advances, high unmet medical needs, and government initiatives are major factors that are expected to drive the development of the treatment market for chronic and cardiovascular disorders in the near future.
  • The strategic developments such as regional expansion, product innovations, and on-going research and developments by the major companies such as Aspen Holdings, Bayer AG, Boehringer Ingelheim GmbH Portola Pharmaceuticals Inc., etc. is likely to boom the market’s growth over the upcoming years.
  • Our analysts recommend that the Asia Pacific region is predicted to witness significant growth attributed to the growing demand for Anticoagulants from China and India.     
  • Expansion of pharmaceuticals companies especially in the emerging market is anticipated to fuel the demand for Anticoagulants drug in the developing regions over the forthcoming years.
  • Strengthening the distribution channel and growing availability of bipolar disorder drugs online may also help the major player to cater to the lucrative growth of the market over the years to come.

Industry Major Market Players

  • Glaxo SmithKline (GSK)
  • Eli Lilly
  • AstraZeneca
  • Pfizer Inc.
  • Janssen Pharmaceuticals
  • AbbVie Inc.
  • Novartis AG
  • Bristol-Myers Squibb Company Allergan Plc.
  • Otsuka Holdings Co. Ltd.

Frequently Asked Questions

Strict enforcement of laws by government authorities mandating Anticoagulants Market.
According to Facts and Factors research report, the global Anticoagulants Market accrued earnings worth approximately XX (USD Billion) in 2020 and is predicted to gain revenue of about XX(USD Billion) by 2028, is set to record a CAGR of nearly XX% over the period from 2021 to 2028.
North America will contribute lucratively towards the global market value over the estimated timeline. The regional market surge is subject to large-scale presence of giant participants in countries such as the U.S. Apart from this, favorable compensation policies along with high acceptance of new Anticoagulants Market will drive regional market trends. With regional governments enforcing strict laws pertaining to drug abuse, the market for Anticoagulants Market in North America is set to witness exponential growth over years to come. Legalization of cannabis in countries such as Canada and U.S. through passing of acts in parliament is likely to enlarge scope of Anticoagulants Market in North America over coming decade.
key questions and why choose us

Related Reports

report img

Corporate Wellness Market

[205+ Pages Report] According to a Facts and Factors market research report, the globalcorporate wellness solutions market is projected to reach USD 100 Billion by 2026 from USD 61.3 Billion in 2020, at a CAGR of 8.5% during the forecast period. Global Corporate Wellness Market: Overview Corpo...

Published Date : 27-Sep-2021 | | Category : | Pages : 205 | Format : Read more

Inquiry for Buying Request Sample
report img

Medical Polymers Market

[203+ Pages Report] According to a survey released by Facts and Factors, the globalmedical polymers market was valued at USD 16,500 Million in 2020 and is predicted to reach USD 28,290 Million by the end of 2026, rising at a CAGR of nearly 9.40% between 2021 and 2026. Global Medical Polymers Mar...

Published Date : 08-Sep-2021 | | Category : | Pages : 203 | Format : Read more

Inquiry for Buying Request Sample